You are here

  • Home
  • Archive
  • Volume 68, Issue 1
  • Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation

Article metrics

Article menu
Download PDFPDF
PostScript
Letter
Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation

 

Online download statistics by month:

Online download statistics by month: January 2018 to March 2024

AbstractFullPdf
Jan 2018834161123
Feb 20185213624
Mar 20183004116
Apr 20182173515
May 20181671411
Jun 2018119105
Jul 20182051511
Aug 20181391711
Sep 2018168106
Oct 2018124185
Nov 201815263
Dec 20183995133
Jan 20192183624
Feb 2019106178
Mar 20191201513
Apr 201986149
May 2019107147
Jun 20191021513
Jul 20199995
Aug 20198385
Sep 201994207
Oct 201979135
Nov 2019100125
Dec 201974114
Jan 20209754
Feb 20209332
Mar 202010739
Apr 20207967
May 202053119
Jun 20206453
Jul 202010456
Aug 20204132
Sep 202089411
Oct 20207644
Nov 20209353
Dec 202010155
Jan 202112116
Feb 202112127
Mar 20211251214
Apr 20217445
May 202111149
Jun 2021633
Jul 2021733
Aug 2021310
Sep 2021732
Oct 20217666
Nov 20216614
Dec 20216422
Jan 202211744
Feb 20228764
Mar 2022108176
Apr 20229768
May 202212281
Jun 202212744
Jul 20224957
Aug 202210264
Sep 20227622
Oct 20227750
Nov 202213328
Dec 20228745
Jan 20237523
Feb 202314622
Mar 20234653
Apr 20233002
May 20235901
Jun 20235032
Jul 20236041
Aug 20233530
Sep 202313425
Oct 20235951
Nov 20235551
Dec 202311131
Jan 20243821
Feb 202412183
Mar 202472104
Total8664822577